Lesson of the week: Tachycardia due to atrial flutter with rapid 1:1 conduction following treatment of atrial fibrillation with flecainide

BMJ (Online)

Volumn 340, Issue 7746, 2010, Pages 595-596

  Taylor, Robert ^a   Gandhi, Manish M ^a   Lloyd, Gavin ^a  

^a ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLECAINIDE; METOPROLOL; ANTIARRHYTHMIC AGENT;

ADULT; ANAMNESIS; CARDIOVERSION; CASE REPORT; CLINICAL FEATURE; EMERGENCY WARD; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SHORT SURVEY; SINUS RHYTHM; TACHYCARDIA; ARTICLE; CHEMICALLY INDUCED DISORDER; HEART BLOCK; MIDDLE AGED;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; FEMALE; FLECAINIDE; HEART BLOCK; HUMANS; MALE; MIDDLE AGED; TACHYCARDIA;

EID: 77949372054     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b4684     Document Type: Short Survey

References (5)

1. National Institute for Health and Clinical Excellence. The management of atrial fibrillation. 2006. www.nice.org.uk/Guidance/CG36.
2. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation - executive summary. Circulation 2006;114:700-52.[Free Full Text]
3. Falk RH. Proarrhythmia in patients treated for atrial fibrillation or flutter. Ann Intern Med 1992;117:141-50.[Abstract/Free Full Text]
4. De Meester A, Machiels JP, Rousseau L, Luwaert R, Chaudron JM. Unusual proarrhythmic effect of flecainide: a contemporary review. Acta Cardiol 1996;51:529-34.[Web of Science][Medline]
5. Kawabata M, Hirao K, Horikawa T, Suzuki K, Motokawa K, Suzuki F, et al. Syncope in patients with atrial flutter during treatment with class 1c antiarrhythmic drugs. J Electrocardiol 2001;34:65-72.[Medline]